Dose-Escalated Radiation Alone or in Combination with Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes from NRG/Radiation Therapy Oncology Group 0815 Randomized Trial
Benjamin Movsas, Joseph P. Rodgers, Mohamed A. Elshaikh, Alvaro A. Martinez, Gerard C. Morton, Daniel J. Krauss, Di Yan, Deborah E. Citrin, Bruce W. Hershatter, Jeff M. Michalski, Rodney J. Ellis, Vivek S. Kavadi, Elizabeth M. Gore, Gary S. Gustafson, Craig A. Schulz, Vikram M. Velker, Adam C. Olson, Fabio L. Cury, Michael A. Papagikos, Theodore G. KarrisonHoward M. Sandler, Deborah W. Bruner
Dive into the research topics of 'Dose-Escalated Radiation Alone or in Combination with Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes from NRG/Radiation Therapy Oncology Group 0815 Randomized Trial'. Together they form a unique fingerprint.